Keywords: global, blockbuster, antibiotics, days, numbered, says, datamonitor
Global blockbuster antibiotics' days are numbered, says Datamonitor report
Article | 14 July 2003
The global antibacterial market is becoming increasingly unattractive to pharmaceutical majors, and firms will be able to maintain short-term market ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
